(Q47251482)

12 January 2018

title

Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy (English)

1 reference

12 January 2018

1 reference

3

1 reference

12 January 2018

author name string

Timothy J Littlewood

1

1 reference

12 January 2018

Johan Nortier

2

1 reference

12 January 2018

Marek Pawlicki

4

1 reference

12 January 2018

Gilbert de Wasch

5

1 reference

12 January 2018

Els Vercammen

6

1 reference

12 January 2018

Wolfgang Schuette

7

1 reference

12 January 2018

Jacques Wils

8

1 reference

12 January 2018

Mathias Freund

9

1 reference

12 January 2018

Epoetin Alfa Study Group

10

1 reference

12 January 2018

publication date

1 December 2003

1 reference

12 January 2018

published in

Hematological Oncology

1 reference

12 January 2018

volume

21

1 reference

12 January 2018

issue

4

1 reference

12 January 2018

page(s)

169-180

1 reference

12 January 2018

Hematologic manifestations of malignancy

cites work

1 reference

Changing clinical presentation of multiple myeloma

21 January 2018

1 reference

7 January 2021

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

7 January 2021

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

1 reference

7 January 2021

MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

7 January 2021

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

7 January 2021

Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin.

1 reference

7 January 2021

Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey

1 reference

7 January 2021

The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study

1 reference

7 January 2021

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

7 January 2021

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

7 January 2021

Frequency and significance of anemia in non-Hodgkin's lymphoma patients.

1 reference

7 January 2021

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

7 January 2021

Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production

1 reference

7 January 2021

Mechanisms of abnormal erythropoiesis in malignancy

1 reference

7 January 2021

Decreased erythropoietin response in patients with the anemia of cancer

1 reference

7 January 2021

Erythropoietin treatment of anemia associated with multiple myeloma

1 reference

7 January 2021

Recombinant human erythropoietin in the treatment of the anaemia of cancer

1 reference

7 January 2021

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

1 reference

7 January 2021

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

7 January 2021

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

7 January 2021

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

1 reference

7 January 2021

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

7 January 2021

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

7 January 2021

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy

1 reference

7 January 2021

Symptomatology of anemia

1 reference

7 January 2021

The impact of hemoglobin levels on treatment outcomes in patients with cancer

1 reference

7 January 2021

Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma

1 reference

7 January 2021

Erythropoietin for anaemia in cancer patients

1 reference

7 January 2021

Evaluation of quality of life in a clinical trial with nonrandom dropout: the effect of epoetin alfa in anemic cancer patients

1 reference

7 January 2021

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

1 reference

7 January 2021

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

7 January 2021

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors

1 reference

7 January 2021

Mantle cell lymphoma: a retrospective study of 121 cases

1 reference

7 January 2021

Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90

1 reference

7 January 2021

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.722

1 reference

12 January 2018

PubMed ID

14735555

1 reference

12 January 2018